www.Pyranosis.com - Recently-discovered information from the Sumerian records by Dr. Scott McQuate exposes secrets that have been hidden for thousands of years within the Cuneiform and even the Bible. This never-before-seen research reveals forbidden knowledge that connects human genetics with Israel, Eden and the Great Pyramid of Egypt. It is some of the most fascinating information you will ever see and challenges all previous religious dogma and scientific curriculum. Go now and discover what the world has never known. www.Pyranosis.com - Also be sure to watch his lecture at http://youtu.be/GEe7jIkn0Js
Through thousands of hours meeting with women from Dallas to Taipei, Sao Paulo to Paris, Neutrogena® uncovered a universal truth – women are stepping back to examine what’s possible in their lives so they can pursue their dreams. Always on a mission to create, innovate, and rethink what’s possible in skincare, Neutrogena® identified this shared value and was inspired to launch its first-ever global campaign: “Neutrogena. See What’s Possible.™”
“Neutrogena® started as a dream, and through scientific discovery, creative thinking and the resilience to defy expectations without any compromises, a brand was born,” said Alicia Sontag, President, Beauty Care, Johnson & Johnson Consumer Inc. “We support women around the world and are proud to help them put their best face forward as they pursue their own dreams – big or small.”
The “Neutrogena. See What’s Possible™” campaign will debut with a commercial voiced by Brand Ambassador and creative consultant Kerry Washington which features real women following their passions. The empowering video brings to life the brand’s point of view on beauty – what really makes a woman beautiful is the ability to look in the mirror and know that anything is possible. In addition, educational and inspiring digital content designed to encourage her along her journey will be leveraged through social platforms in over 27 countries around the world, making this the largest digitally-driven campaign the brand has ever executed.
To view the multimedia release go to:
http://www.multivu.com/players/English/7770451-neutrogena-see-what-s-possible/
Featuring a noted cancer researcher, animal behaviorists and a 14-year-old entrepreneur who developed a new product to ease pets’ separation anxiety, Purina’s second Better With Pets Summit emphasized how technology and scientific advances are leading to a brighter future with our pets. The daylong event, Tuesday, in New York City featured 15 expert presentations on scientific, nutritional and behavioral innovations to help better understand why our lives are better with pets.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7325551-purina-better-with-pets-summit-2014/
A decade ago Turtle Beach Corporation (NASDAQ: HEAR), a leading audio technology company for over 40 years, pioneered the console gaming headset category and is set to do so again in 2016 with its revolutionary Turtle Beach® Elite Pro Tournament Gaming Headset, Elite Pro Tactical Audio Controller (T.A.C.) and Elite Pro accessories designed for competitive gamers, which establishes a new standard for eSports gaming audio performance and comfort. Turtle Beach’s “Elite” series products represent the highest level in audio and build quality, and the all-new Elite Pro Headset, T.A.C. and Elite Pro accessories are the Company’s all-new line of competitive gaming audio gear created to meet the demands of today’s professional and aspiring pro teams and players.
The Elite Pro Headset’s journey began in 2013. Seeing the consistent growth and popularity of eSports, Turtle Beach launched a comprehensive scientific research program to deeply examine the needs of professional and hardcore gamers as it pertained to game audio, communicating with teammates, and overall comfort. The result is the all-new Elite Pro Tournament Gaming Headset – a ground-up redesign of the competitive gaming headset that brings to market multiple first-and-only innovations in the core mechanics of headset design, weight and fit. Not only does the Elite Pro Headset provide Turtle Beach’s best-in-class game audio and chat performance, but also delivers groundbreaking comfort-driven technologies, including the ComforTec® Fit System with multiple adjustment points for a truly personalized headset fit and feel, Aerofit® Ear Cushions that stay cool in the heat of battle, and Turtle Beach’s all-new patented ProSpecs® Glasses Relief System that finally makes wearing a gaming headset comfortable for players who wear glasses.
To view the multimedia release go to:
http://www.multivu.com/players/English/7537953-turtle-beach-optic-gaming-elite-pro/
Barrister, peer and Vice-President of the Patients Association Baroness Helena Kennedy has joined a panel of internationally recognised experts for the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
Organised and funded by Astellas, a progressive pharmaceutical company that explores the frontiers of scientific discovery to translate new knowledge into innovative, reliable medicines, the Astellas Innovation Debates are a series of annual events that bring together some of the world’s most progressive thinkers to discuss the role of innovation in solving some of the greatest challenges of our time.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7424051-helena-kennedy-astellas-debate/
George Freeman MP, the Minister for Life Sciences, will give the keynote address at the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
Organised and funded by Astellas, a progressive pharmaceutical company that explores the frontiers of scientific discovery to translate new knowledge into innovative, reliable medicines, the Astellas Innovation Debates are a series of annual events that bring together some of the world’s most progressive thinkers to discuss the role of innovation in solving some of the greatest challenges of our time.
George Freeman’s keynote address will outline the Government’s aim to develop, assess and adopt new drugs, devices and diagnostics as we move towards 21st century, personalised healthcare.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7423951-george-freeman-astellas-debate/
In Carbide Tipped Pens, over a dozen of today’s most creative imaginations explore these frontiers, carrying on the grand tradition of such legendary masters as Isaac Asimov, Robert Heinlein, and John W. Campbell, while bringing hard science fiction into the 21st century by extrapolating from the latest scientific developments and discoveries. Find out more at http://us.macmillan.com/books/9780765334305. Science fiction
Visit: http://www.SanjayCPatel.com ~ God Is Real - The Stunning NEW Convergence of Science and Spirituality. Over 100 New Proofs of God from the Bible, Ancient Yoga, and Modern Science!
Finally, after centuries of search, the holy grail of all proofs demonstrating God is real has arrived. Whether you are interested in proof of God for yourself or a skeptical teenager, these new discoveries proving God is real will forever change the way you view the ancient scriptures of Israel and their metaphorical descriptions of our world. It turns out that the ancient metaphors were not ad hoc. They had a deeper meaning and were meticulously modeled.
Hugely important, some of them have been published in three international science journals -- the gold standard of scientific research -- and hailed by many as one of the most important discoveries of this century.
By Sanjay C. Patel Visit http://www.SanjayCPatel.com
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
The Amgen Foundation announced today that it will invest more than $4 million to support and strengthen the Amgen Biotech Experience program across the United States, Puerto Rico, United Kingdom and Ireland. The Amgen Biotech Experience includes an engaging series of labs that effectively bring biotechnology into classrooms. This new commitment will also strengthen the program’s alignment with the United States’ Next Generation Science Standards, which are focused on engaging students in more authentic science learning experiences. With the support of Education Development Center, Inc. (EDC), the global nonprofit leading the Amgen Biotech Experience Program Office, the investment is expected to empower 1,000 teachers who will reach more than 150,000 new students with the labs over the next two years.
“We are very excited to extend our commitment to the Amgen Biotech Experience, a program that began 25 years ago, with the intent to ignite a deep passion for innovation and scientific discovery in students,” said Robert A. Bradway, chairman and chief executive officer of Amgen. “This program, which provides advanced biotech curriculum and professional-grade lab equipment at no cost to schools, has opened countless students’ eyes to the world of biotechnology, fueling potential long term advancements to both medicine and society.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7414055-amgen-biotech-experience-grant/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
